{"title":"2型糖尿病患者富血小板纤维蛋白对人牙髓干细胞增殖的影响(体外研究)","authors":"Mona Amer, M. Elhindawy, A. Zaher","doi":"10.21608/adjg.2022.73553.1355","DOIUrl":null,"url":null,"abstract":"Purpose : This study was carried out in order to assess the effect of 10% PRF exudate obtained from controlled type 2 diabetic patients on proliferation capacity of dental pulp stem cells (DPSCs). Then 1% PRF exudate obtained from controlled type 2 diabetic patients was tested for osteogenic capability after 1 week. Material and methods: PRF exudates were prepared using the direct method from 8 healthy donors (control group) and 8 controlled type 2 diabetic patients (study group). In 96-well plates, DPSCs harvested from pulp tissue of impacted lower third molar were treated with 10% PRF exudate obtained from healthy donors and controlled type 2 diabetic patients for 1,3 and 5 days. The effects of exudates on proliferation and cell viability were tested using the MTS assay. For osteogenic capability, DPSCs were treated with 1%PRF exudate obtained from healthy donors and controlled type 2 diabetic patients supplemented with osteogenic medium for 1week and the osteodifferentiation assay was held using alizarin red stain with ELIZA reader. All data were subjected into one-way Anova statistical analysis. Results: The concentrations of 10% and 1% PRF exudates obtained from controlled type 2 diabetic patients had proliferative and osteoinductive effects on DPSCs comparable to that of the healthy individuals. Conclusion: Based on our study, controlled type 2 diabetic patients can be treated similar to their Unaffected peers using 10% PRF exudates as the optimal concentration for DPSCs proliferation and 1% PRF exudates as the optimal concentration for DPSCs osteodifferentiation and formation of mineralized nodules in 7 days. which chronic hyperglycemia is the core finding. Either defect in insulin secretion or defect in insulin action or both are","PeriodicalId":7493,"journal":{"name":"Al-Azhar Dental Journal for Girls","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Possible Proliferative Impact of Human Platelet-Rich Fibrin Obtained From Controlled Type 2 Diabetic Patients on Human Dental Pulp Stem Cells (In Vitro Study)\",\"authors\":\"Mona Amer, M. Elhindawy, A. Zaher\",\"doi\":\"10.21608/adjg.2022.73553.1355\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose : This study was carried out in order to assess the effect of 10% PRF exudate obtained from controlled type 2 diabetic patients on proliferation capacity of dental pulp stem cells (DPSCs). Then 1% PRF exudate obtained from controlled type 2 diabetic patients was tested for osteogenic capability after 1 week. Material and methods: PRF exudates were prepared using the direct method from 8 healthy donors (control group) and 8 controlled type 2 diabetic patients (study group). In 96-well plates, DPSCs harvested from pulp tissue of impacted lower third molar were treated with 10% PRF exudate obtained from healthy donors and controlled type 2 diabetic patients for 1,3 and 5 days. The effects of exudates on proliferation and cell viability were tested using the MTS assay. For osteogenic capability, DPSCs were treated with 1%PRF exudate obtained from healthy donors and controlled type 2 diabetic patients supplemented with osteogenic medium for 1week and the osteodifferentiation assay was held using alizarin red stain with ELIZA reader. All data were subjected into one-way Anova statistical analysis. Results: The concentrations of 10% and 1% PRF exudates obtained from controlled type 2 diabetic patients had proliferative and osteoinductive effects on DPSCs comparable to that of the healthy individuals. Conclusion: Based on our study, controlled type 2 diabetic patients can be treated similar to their Unaffected peers using 10% PRF exudates as the optimal concentration for DPSCs proliferation and 1% PRF exudates as the optimal concentration for DPSCs osteodifferentiation and formation of mineralized nodules in 7 days. which chronic hyperglycemia is the core finding. Either defect in insulin secretion or defect in insulin action or both are\",\"PeriodicalId\":7493,\"journal\":{\"name\":\"Al-Azhar Dental Journal for Girls\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Al-Azhar Dental Journal for Girls\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/adjg.2022.73553.1355\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Al-Azhar Dental Journal for Girls","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/adjg.2022.73553.1355","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Possible Proliferative Impact of Human Platelet-Rich Fibrin Obtained From Controlled Type 2 Diabetic Patients on Human Dental Pulp Stem Cells (In Vitro Study)
Purpose : This study was carried out in order to assess the effect of 10% PRF exudate obtained from controlled type 2 diabetic patients on proliferation capacity of dental pulp stem cells (DPSCs). Then 1% PRF exudate obtained from controlled type 2 diabetic patients was tested for osteogenic capability after 1 week. Material and methods: PRF exudates were prepared using the direct method from 8 healthy donors (control group) and 8 controlled type 2 diabetic patients (study group). In 96-well plates, DPSCs harvested from pulp tissue of impacted lower third molar were treated with 10% PRF exudate obtained from healthy donors and controlled type 2 diabetic patients for 1,3 and 5 days. The effects of exudates on proliferation and cell viability were tested using the MTS assay. For osteogenic capability, DPSCs were treated with 1%PRF exudate obtained from healthy donors and controlled type 2 diabetic patients supplemented with osteogenic medium for 1week and the osteodifferentiation assay was held using alizarin red stain with ELIZA reader. All data were subjected into one-way Anova statistical analysis. Results: The concentrations of 10% and 1% PRF exudates obtained from controlled type 2 diabetic patients had proliferative and osteoinductive effects on DPSCs comparable to that of the healthy individuals. Conclusion: Based on our study, controlled type 2 diabetic patients can be treated similar to their Unaffected peers using 10% PRF exudates as the optimal concentration for DPSCs proliferation and 1% PRF exudates as the optimal concentration for DPSCs osteodifferentiation and formation of mineralized nodules in 7 days. which chronic hyperglycemia is the core finding. Either defect in insulin secretion or defect in insulin action or both are